Evoke (LON:EVOK - Get Free Report) had its target price lifted by research analysts at JPMorgan Chase & Co. from GBX 77 ($1.05) to GBX 80 ($1.09) in a note issued to investors on Thursday,London Stock Exchange reports. The firm presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s target price indicates a potential upside of 25.39% from the company's current price.
Evoke Stock Down 1.4%
Evoke stock opened at GBX 63.80 ($0.87) on Thursday. Evoke has a 52 week low of GBX 36.70 ($0.50) and a 52 week high of GBX 90.95 ($1.24). The business has a 50-day simple moving average of GBX 56.53 and a 200 day simple moving average of GBX 59.88. The stock has a market cap of £284.54 million, a price-to-earnings ratio of -1.59 and a beta of 0.84.
Insider Transactions at Evoke
In other news, insider Sean Wilkins acquired 101,652 shares of the business's stock in a transaction dated Wednesday, April 30th. The stock was purchased at an average cost of GBX 50 ($0.68) per share, for a total transaction of £50,826 ($69,075.84). Also, insider Per Widerström acquired 68,958 shares of the business's stock in a transaction dated Friday, May 23rd. The stock was purchased at an average price of GBX 54 ($0.73) per share, with a total value of £37,237.32 ($50,607.94). Insiders bought a total of 202,269 shares of company stock valued at $10,515,918 over the last quarter. Company insiders own 27.00% of the company's stock.
About Evoke
(
Get Free Report)
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
